Keyword: Boehringer Ingelheim

News

Boehringer to Expand Greek Production Site for New Medicines

19.01.2024 -

German drugmaker Boehringer Ingelheim is investing €120 million in an upgrade and expansion of its facility in Koropi, Greece, that will increase the company's capacity...

News

Gingko Enters Dyes and Drugs Partnerships

11.05.2023 -

US biology company Ginkgo Bioworks has announced two separate partnerships, one on natural colors and dyes with Octarine Bio and the other on novel therapeutic molecules...

News

Boehringer Ingelheim, Evotec and BioMérieux Link on AMR

14.07.2022 -

German biopharma Boehringer Ingelheim, compatriot CDMO Evotec and French diagnostics firm BioMérieux have formed a joint venture to develop a new approach to fight the...

Markets & Companies

Ramping Up Biomanufacturing Capacity

20.04.2022 -

Biomanufacturing for both traditional biologics and new modalities, such as cell and gene therapies, continues to be an active area of investment for CDMOs/CMOS. Some of...

Strategy & Management

BearingPoint Client Success Story: Boehringer Ingelheim increases Data Accuracy by leveraging Robotic Process Automation

06.12.2021 -

Storage conditions play a vital role in the entire supply chain of pharmaceutical products and must comply with strict regulations. From manufacturers to patients...

News

Boehringer Inaugurates BioPharma Plant in Austria

11.10.2021 -

Boehringer Ingelheim has inaugurated its Large Scale Cell Culture (LSCC) biopharmaceutical plant at Vienna, Austria. Built over a period of six years at a cost of more...

News

The Transition to Digitalization in the Pharmaceutical Industry

15.09.2021 -

ISPE and its members are developing the roadmap to introduce Industry 4.0, also called the Smart Factory, at the pharmaceutical industry as Pharma 4.0 – an operating...

News

Expert Statement: Viola Meisterling, Boehringer Ingelheim

06.09.2021 -

ISPE and its members are developing the roadmap to introduce Industry 4.0, also called the Smart Factory, at the pharmaceutical industry as Pharma 4.0 – an operating...